Table 3

Accessibility and quality of drug company payment data disclosed via centralised industry databases and eurosfordocs.eu

CountryName of regulationOverseeing authority and database web link2–4Payment data accessibility*Payment data quality*
Document formatSingle data templateDatabase searchableCustomisable summary statisticsDatabase downloadableCharacteristics includedAggregation of paymentsPayments with or without taxesUnique identifiers
Self-regulation at the European level—minimum requirements
EFPIAEFPIA CodeEFPIANot regulatedYes (‘EFPIA disclosure template’), but deviations allowedNot regulatedNot regulatedNot regulatedDonors; recipients; recipient location; payment categories and amounts; yearAnnually per payment typeNo single rule, each company sets its own rules for VAT reporting which are published separately from payment disclosuresOptional
Centralised online industry databases
UKABPI Code of PracticeAssociation of the British Pharmaceutical IndustryWebsite, XLSYesYesNoYesDonors; recipients; recipient categories (healthcare professionals) and location; payment categories and amounts; year; web links with further descriptions for some paymentsAnnually per payment type for healthcare professionals; payments to healthcare organisations itemisedNo single rule, each company sets its own rules for VAT reporting which are published separately from payment disclosuresNo
Czech RepublicEticky Kodex AIPFAsociace inovativního farmaceutického průmysluWebsiteYesYes (but requires donor or recipient identifiers)NoNoDonors; donor location; recipients; recipient location; payment categories and amounts; yearAnnually per payment typeNo single rule, each company sets its own rules for VAT reporting which are published separately from payment disclosuresRecipient and donor identifiers
DenmarkEthical rules for the pharmaceutical industry’s donations and grantsLægemiddelindustriforeningenReadable PDFsYesNoNoYesDonors; project name; recipients; product name; funded activity; payment goal; timescale of funded activity; payment amount and form (cash or benefit in kind)NoUnclearNo
GreeceSFEE Code of ConductHellenic Association of Pharmaceutical CompaniesWebsiteYesNoNoNoDonors; recipients; recipient categories; payment descriptions, categories goals, and amounts; dateNoNo single rule, each company sets its own rules for VAT reporting which are published separately from payment disclosuresNo
IrelandCode of Practice of the Pharmaceutical IndustryIrish Pharmaceutical Healthcare AssociationWebsiteYesNoNoNoDonors; recipients; recipient location; payment categories and amounts; yearAnnually per payment typeNo single rule, each company sets its own rules for VAT reporting which are published separately from payment disclosuresPartial (recipient identifiers used by some companies)
Industry data integrated within an independent database†
Euros fordocs. euCodes of conduct in countries where data was collected‡N/AWebsite, XLSYesYesYesYesDonors; recipients; recipient location; payment categories and amounts; yearAnnually per payment type for healthcare professionals (all countries). Annually per payment type for healthcare organisations in all countries but the UK, where payments to healthcare organisations are itemisedNo single rule, each company sets its own rules for VAT reporting which are published separately from payment disclosuresSpain: recipient identifiers.
Other countries: No
  • *Lighter colours indicate, respectively, higher, and darker colours—lower, data accessibility and quality. In the upper part of the table, the centralised industry databases are presented in the descending order of their overall data accessibility and quality, that is, the greater overall number of lighter cells a database has the higher its position within the table. Databases with equal numbers of lighter and darker cells are sorted alphabetically.

  • †The disclosure requirements ordinarily cover both healthcare professionals and organisations. The exceptions are the database run by the Danish pharmaceutical industry trade group (donations to hospitals) and the database run by the Greek pharmaceutical industry trade group (only payments to healthcare organisations).

  • ‡Ireland, Italy, Germany, Spain, Sweden, Switzerland and the UK.

  • §Web links are accurate as of May 2021.

  • ¶Some pharmaceutical industry trade groups create and delegate some responsibility for the everyday operation of their codes to sub-divisions such as the Ethical Committee for the Pharmaceutical Industry (established by Denmark’s LIF) or the Prescription Medicines Code of Practice Authority (established by the UK’s ABPI). However, the ultimate responsibility for managing and overseeing the codes is with the trade group.

  • EFPIA, European Federation of Pharmaceutical Industries and Associations; VAT, Value-added tax.